Speed Meets Expertise: Inside Vetter’s Clinical Drug Product Manufacturing Sites

Join our free webcast on October 9 at 9:00–9:30 a.m. EST | 3:00–3:30 p.m. CET

Speed Meets Expertise: Inside Vetter’s Clinical Drug Product Manufacturing Sites in the US and EU

Discover how our dedicated clinical manufacturing sites in the US and EU provide the technical expertise and agility needed to advance your clinical batch supply.

The transition from preclinical to clinical development is a critical step in the development of a drug product.

As your molecule enters first in-human trials, your manufacturing needs evolve rapidly – from clinical material supply to analytical testing, and regulatory readiness.

At Vetter, we offer aligned processes and reliable support tailored to your individual needs during key development phases. With over 45 years of experience in aseptic filling of complex compounds and sensitive biologics, we are committed to meeting your critical timelines while maintaining high quality standards.

Meet our presenters

Director Global Clinical Business Development

Paul Earnshaw

Paul Earnshaw has worked in the biotech and pharmaceutical industry for over 20 years, including nine years at Genentech.

Since joining Vetter, he has served in a business development role, supporting current and prospective customers at the company's clinical-only facilities in Chicago, Illinois, and Rankweil, Austria.

He holds a Bachelor of Science degree in Exercise Physiology from the University of California, Davis, and a Master of Business Administration from California State University, Sacramento.

Director Supply Chain & Project Management US

Mark Rauckhorst

Mark Rauckhorst joined Vetter Development Services USA in 2013 as a project manager, focusing on early-phase clinical projects at Vetter's first US site in Chicago.

Prior to this, he was a project manager at Regis Technologies, where he managed custom synthesis manufacturing projects involving process research and development, non-cGMP manufacturing and cGMP production of phase I and II clinical trial materials.

He began his professional career as a synthetic organic chemist specialising in small molecules at Pharmacia Upjohn and Pfizer.

He received his Master’s degree in Organic Chemistry from The Ohio State University and his MBA from the University of Rhode Island.

Director Supply Chain & Project Management Austria

Garath Duffy

Garath Duffy joined Vetter in 2009 at the Ravensburg manufacturing site, focusing on compounding.

In 2011, he joined the Process Implementation Team, guiding Tech Transfer activities for Phase III and Process Qualification for a number of customers across a range of delivery systems.

From 2013 until 2020, he worked as a project manager, heading up multidisciplinary teams on the same tech transfer projects. In 2020, he took on the role of Director Supply Chain & Project Management Austria at our new facility in Rankweil, Austria.

Garath is a biochemist who studied at Queen's University Belfast and the Open University.